"The global vaccine supply problem is related to neoliberalism"

Get Started. It's Free
or sign up with your email address
"The global vaccine supply problem is related to neoliberalism" by Mind Map: "The global vaccine supply problem is related to neoliberalism"

1. Neoliberalism favors free market capitalisms

1.1. Most vaccine makers have targeted locations where profits are highest.

1.1.1. “But it’s not right that younger, healthier adults in rich countries are vaccinated before health workers and older people in poorer countries. There will be enough vaccine for everyone.” Smaller countries that have bought into neoliberalism are smaller countries are now suffering to as bigger countries are getting the vaccine.

2. Smaller and poorer countries are getting smaller amounts, as bigger and richer countries are getting more.

2.1. Guinea was given "Just 25 doses have been given in one lowest income country -- not 25 million, not 25,000 -- just 25.

2.2. "Due to the ultra-cold storage needed for the Pfizer vaccine, it is more expensive and harder to use than some rivals"

2.2.1. Smaller countries don't have the resources to store many of the vaccines

3. Companies are giving back to their biggest donors first

3.1. "The European Union, which counts among its 27 members many of the world’s richest countries, for getting vaccines for its 450 million citizens and being the single largest donor."

3.1.1. The Problem with this, is that countries that aren't able to donate are being left out even though they are going through the same pandemic "..one poor country received a mere 25 vaccine doses while over 39 million doses have been administered in nearly 50 richer nations.

4. Inequality is being showed in the world

4.1. “But we now face the real danger that even as vaccines bring hope to some, they become another brick in the wall of inequality between the worlds of the world’s haves and have-nots.”

4.1.1. The world is divided by a dollar sign Covax is looking to break the barrier and create equal opportunity for the vaccine "which aims to get vaccines out to all countries, rich or poor, based on need, has so far secured 2 billion vaccine doses from five producers and options on a billion doses more."